日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Urinary metabolomics identifies isoleucine as a prognostic biomarker for progression of diabetic kidney disease

尿液代谢组学鉴定出异亮氨酸是糖尿病肾病进展的预后生物标志物

期刊:Frontiers in Endocrinology
影响因子:4.6
doi:10.3389/fendo.2026.1787886
Li, Yufei; Yun, Donghwan; Kwak, Soo Heon; Han, Seung Seok; Cho, Joo-Youn
糖尿病
糖尿病肾病
代谢
发表日期：2026
文献求助 收藏

Lipid profiling in nontuberculous mycobacterial pulmonary disease based on geospatial locations and disease severity

基于地理位置和疾病严重程度的非结核分枝杆菌肺病脂质谱分析

期刊:Erj Open Research
影响因子:4
doi:10.1183/23120541.00275-2025
Kim, Jungeun; Kim, Kyeong-Seog; Koh, Jaemoon; Na, Kwon Joong; Kim, Joong-Yub; Yim, Jae-Joon; Cho, Joo-Youn; Kwak, Nakwon
发表日期：2026
文献求助 收藏

Integrated genomics and metabolomics to identify cause-specific biomarkers for chronic kidney disease in a Korean population

整合基因组学和代谢组学技术，以识别韩国人群慢性肾脏病的病因特异性生物标志物

期刊:Kidney Research and Clinical Practice
影响因子:3.8
doi:10.23876/j.krcp.24.135
Kang, Min Woo; Kim, Ji-Eun; Kang, Jihyun; Kim, Seonmi; Park, JooYong; Bae, Sohyun; Kim, Yon Su; Choi, Ji-Yeob; Cho, Joo-Youn; Han, Seung Seok
代谢
发表日期：2026
文献求助 收藏

Exploring LEPR-Linked Metabolic Diversity through Gut Microbiome-Metabolome Network Analysis in Non-Obese Adults

通过肠道微生物组-代谢组网络分析探索非肥胖成年人中与LEPR相关的代谢多样性

期刊:Biomolecules & Therapeutics
影响因子:3.2
doi:10.4062/biomolther.2025.161
Kim, Kyeong-Seog; Cho, Joo-Youn; Park, Ye Chan; Hong, Jang Hee; Jung, Jin-Gyu; Sunwoo, Jung
微生物学
肥胖
LEP
代谢
发表日期：2026
文献求助 收藏

Pharmacokinetic comparison of ezetimibe/rosuvastatin/telmisartan 10/20/80 mg fixed-dose combination versus coadministration of separate tablets in healthy participants

在健康受试者中，对依泽替米贝/瑞舒伐他汀/替米沙坦 10/20/80 mg 固定剂量复方制剂与分别服用各片剂的药代动力学进行比较

期刊:Naunyn-Schmiedebergs Archives of Pharmacology
影响因子:3.1
doi:10.1007/s00210-025-04903-4
Goh, Seoyoung; Huh, Ki Young; Lee, SeungHwan; Cho, Joo-Youn; Yu, Kyung-Sang
发表日期：2026
文献求助 收藏

Exploratory Evaluation of Solanidine as an Endogenous Marker for CYP2D6-Mediated Drug-Drug-Gene Interactions of Venlafaxine in Koreans

探索性评价茄啶作为文拉法辛在韩国人体内CYP2D6介导的药物-药物-基因相互作用的内源性标志物

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.70564
Bae, Sungyeun; Lee, Ga-Yeong; Yang, Eunsol; Chae, Woori; Yu, Kyung-Sang; Cho, Joo-Youn; Kim, Anhye; Gu, Namyi; Lee, SeungHwan
发表日期：2026
文献求助 收藏

Exploratory comparative pharmacokinetic study of a fixed-dose combination of telmisartan/amlodipine/chlorthalidone: half-dose (20/2.5/6.25 mg) versus conventional dose (40/5/12.5 mg)

替米沙坦/氨氯地平/氯噻酮固定剂量组合的探索性比较药代动力学研究：半剂量（20/2.5/6.25 mg）与常规剂量（40/5/12.5 mg）

期刊:Translational and Clinical Pharmacology
影响因子:1.5
doi:10.12793/tcp.2026.34.e5
Chang, Kyungrin; Won, Heejae; Lee, Taewon; Kwon, Soonkeun; Lee, Seung Hwan; Cho, Joo-Youn; Yu, Kyung-Sang
发表日期：2026
文献求助 收藏

Correction: Pharmacokinetics of post-transplant cyclophosphamide and its associations with clinical outcomes in pediatric haploidentical hematopoietic stem cell transplantation

更正：移植后环磷酰胺的药代动力学及其与儿童单倍体相合造血干细胞移植临床结果的关系

期刊:Biomarker Research
影响因子:11.5
doi:10.1186/s40364-025-00781-3
Hong, Kyung Taek; Bae, Sungyeun; Sunwoo, Yoon; Lee, Juyeon; Park, Hyun Jin; Kim, Bo Kyung; Choi, Jung Yoon; Cho, Joo-Youn; Yu, Kyung-Sang; Oh, Jaeseong; Kang, Hyoung Jin
干细胞
发育与干细胞
细胞生物学
发表日期：2025
文献求助 收藏

Pharmacokinetics of post-transplant cyclophosphamide and its associations with clinical outcomes in pediatric haploidentical hematopoietic stem cell transplantation

儿童单倍体相合造血干细胞移植后环磷酰胺的药代动力学及其与临床结局的关系

期刊:Biomarker Research
影响因子:11.5
doi:10.1186/s40364-025-00749-3
Hong, Kyung Taek; Bae, Sungyeun; Sunwoo, Yoon; Lee, Juyeon; Park, Hyun Jin; Kim, Bo Kyung; Choi, Jung Yoon; Cho, Joo-Youn; Yu, Kyung-Sang; Oh, Jaeseong; Kang, Hyoung Jin
细胞生物学
发育与干细胞
干细胞
发表日期：2025
文献求助 收藏

Accurate Determination of Circulatory Lipids Using a Combination of HILIC-MRM and RPLC-PRM

结合HILIC-MRM和RPLC-PRM技术精确测定循环脂质

期刊:Analytical Chemistry
影响因子:6.7
doi:10.1021/acs.analchem.4c06409
Kim, Kyeong-Seog; Lee, Jae-Seung; Han, Seung Seok; Cho, Joo-Youn
发表日期：2025
文献求助 收藏